• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢吡肟对头孢他啶和头孢噻肟耐药革兰阴性菌的活性及其与β-内酰胺酶水平的关系。

Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels.

作者信息

Fung-Tomc J, Dougherty T J, DeOrio F J, Simich-Jacobson V, Kessler R E

机构信息

Department of Microbiology, Bristol-Myers Company, Wallingford, Connecticut 06492.

出版信息

Antimicrob Agents Chemother. 1989 Apr;33(4):498-502. doi: 10.1128/AAC.33.4.498.

DOI:10.1128/AAC.33.4.498
PMID:2499250
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC172467/
Abstract

One hundred clinical isolates resistant to ceftazidime and/or cefotaxime were examined for susceptibility to cefepime. The most frequently encountered ceftazidime-cefotaxime-resistant strains belonged to the genera Enterobacter, Pseudomonas, and Citrobacter. Among these strains, 92% were resistant to cefoperazone, 91% were resistant to cefotaxime, 84% were resistant to ceftazidime, and 6% were resistant to cefepime. Of the members of the family Enterobacteriaceae, 57% were resistant to ceftriaxone. The six strains resistant to cefepime were all Pseudomonas aeruginosa and were resistant to both cefotaxime and ceftazidime. Cefepime-resistant P. aeruginosa strains had exceptionally high levels of beta-lactamase activity, higher than the levels found in strains resistant to ceftazidime but susceptible to cefepime. The beta-lactamases from the cefepime-resistant strains were type I (Richmond-Sykes), were constitutively produced, and did not have increased affinity or hydrolytic activity for cefepime. Thus, cefepime was active against most gram-negative bacteria which have developed resistance to the broad-spectrum cephalosporins, and resistance to cefepime in P. aeruginosa appears to be associated with higher beta-lactamase levels than in cefepime-susceptible strains.

摘要

检测了100株对头孢他啶和/或头孢噻肟耐药的临床分离株对头孢吡肟的敏感性。最常见的对头孢他啶-头孢噻肟耐药的菌株属于肠杆菌属、假单胞菌属和柠檬酸杆菌属。在这些菌株中,92%对头孢哌酮耐药,91%对头孢噻肟耐药,84%对头孢他啶耐药,6%对头孢吡肟耐药。肠杆菌科成员中,57%对头孢曲松耐药。6株对头孢吡肟耐药的菌株均为铜绿假单胞菌,且对头孢噻肟和头孢他啶均耐药。对头孢吡肟耐药的铜绿假单胞菌菌株具有异常高水平的β-内酰胺酶活性,高于对头孢他啶耐药但对头孢吡肟敏感的菌株。来自对头孢吡肟耐药菌株的β-内酰胺酶为I型(里士满-赛克斯型),为组成型产生,对头孢吡肟没有增加的亲和力或水解活性。因此,头孢吡肟对大多数已对广谱头孢菌素产生耐药性的革兰氏阴性菌具有活性,铜绿假单胞菌对头孢吡肟的耐药性似乎与比头孢吡肟敏感菌株更高的β-内酰胺酶水平有关。

相似文献

1
Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels.头孢吡肟对头孢他啶和头孢噻肟耐药革兰阴性菌的活性及其与β-内酰胺酶水平的关系。
Antimicrob Agents Chemother. 1989 Apr;33(4):498-502. doi: 10.1128/AAC.33.4.498.
2
Activity of cefepime against ceftazidime-resistant gram-negative bacilli using low and high inocula.使用低接种量和高接种量时头孢吡肟对头孢他啶耐药革兰氏阴性杆菌的活性
J Antimicrob Chemother. 1995 Jun;35(6):765-73. doi: 10.1093/jac/35.6.765.
3
[The effect of cefepime on ceftazidime, cefotaxime and imipenem resistant strains of Acinetobacter, Xanthomonas, Pseudomonas, Flavobacterium, Sphingobacterium and on producers of extended spectrum beta-lactamases (ESBL) with resistance transfer].头孢吡肟对头孢他啶、头孢噻肟和亚胺培南耐药的不动杆菌、黄单胞菌、假单胞菌、黄杆菌、鞘氨醇杆菌菌株以及对具有耐药性转移的超广谱β-内酰胺酶(ESBL)产生菌的影响
Cas Lek Cesk. 1997 Mar 12;136(5):154-6.
4
Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.使用Etest方法对哥伦比亚六种广谱β-内酰胺类抗生素的耐药性进行多中心评估。哥伦比亚抗菌药物耐药性研究小组。
Diagn Microbiol Infect Dis. 1997 Dec;29(4):265-72. doi: 10.1016/s0732-8893(97)00157-0.
5
Frequency of in vitro resistance of Pseudomonas aeruginosa to cefepime, ceftazidime, and cefotaxime.铜绿假单胞菌对头孢吡肟、头孢他啶和头孢噻肟的体外耐药频率。
Antimicrob Agents Chemother. 1988 Sep;32(9):1443-5. doi: 10.1128/AAC.32.9.1443.
6
Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.头孢吡肟(BMY - 28142)与头孢他啶、头孢唑南、头孢噻肟和头孢甲肟的体外及体内抗菌活性比较。
Drugs Exp Clin Res. 1989;15(1):1-10.
7
Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa.新型头孢菌素头孢利定、头孢吡肟和头孢匹罗对头孢他啶或亚胺培南耐药铜绿假单胞菌的体外活性比较
J Antimicrob Chemother. 1992 Nov;30(5):633-41. doi: 10.1093/jac/30.5.633.
8
Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.对第三代头孢菌素耐药的革兰氏阴性杆菌:β-内酰胺酶特性及对Sch 34343的敏感性
J Antimicrob Chemother. 1985 Jun;15 Suppl C:119-32. doi: 10.1093/jac/15.suppl_c.119.
9
Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.头孢吡肟对产布什I组β-内酰胺酶且对头孢他啶耐药菌株的抗菌活性。一项多实验室的国内及国际临床分离株研究。
Diagn Microbiol Infect Dis. 1994 May;19(1):33-8. doi: 10.1016/0732-8893(94)90048-5.
10
Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.新型胃肠外头孢菌素FK-037抗菌活性的多中心比较研究
Eur J Clin Microbiol Infect Dis. 1995 Mar;14(3):244-52. doi: 10.1007/BF02310366.

引用本文的文献

1
Involvement of the gene in emergence of a peculiar resistance phenotype in .该基因在……中一种特殊抗性表型出现过程中的作用。 (注:原文中部分内容缺失,翻译可能不够完整准确)
Front Cell Infect Microbiol. 2025 May 13;15:1545157. doi: 10.3389/fcimb.2025.1545157. eCollection 2025.
2
Molecular Evolutionary Analyses of the -Derived Cephalosporinase Gene.源自 - 的头孢菌素酶基因的分子进化分析。
Microorganisms. 2023 Mar 1;11(3):635. doi: 10.3390/microorganisms11030635.
3
spp.: Update on Taxonomy, Clinical Aspects, and Emerging Antimicrobial Resistance.spp.:分类学、临床方面和新出现的抗菌药物耐药性的最新进展。
Clin Microbiol Rev. 2019 Jul 17;32(4). doi: 10.1128/CMR.00002-19. Print 2019 Sep 18.
4
Evaluation of evidence for pharmacokinetics-pharmacodynamics-based dose optimization of antimicrobials for treating Gram-negative infections in neonates.基于药代动力学-药效学的抗菌药物剂量优化用于治疗新生儿革兰氏阴性菌感染的证据评估。
Indian J Med Res. 2017 Mar;145(3):299-316. doi: 10.4103/ijmr.IJMR_723_15.
5
Improved Accuracy of Cefepime Susceptibility Testing for Extended-Spectrum-Beta-Lactamase-Producing Enterobacteriaceae with an On-Demand Digital Dispensing Method.采用按需数字分配法提高对产超广谱β-内酰胺酶肠杆菌科细菌头孢吡肟药敏试验的准确性
J Clin Microbiol. 2017 Feb;55(2):470-478. doi: 10.1128/JCM.02128-16. Epub 2016 Nov 30.
6
Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.β-内酰胺酶AmpC突变增加铜绿假单胞菌分离株对抗假单胞菌头孢菌素的耐药性。
Antimicrob Agents Chemother. 2015 Oct;59(10):6248-55. doi: 10.1128/AAC.00825-15. Epub 2015 Jul 27.
7
Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology.采用美国国家临床实验室标准委员会(NCCLS)的超广谱β-内酰胺酶(ESBL)检测方法,对产AmpC酶和ESBL的大肠埃希菌及肺炎克雷伯菌临床分离株,检测接种量和β-内酰胺酶活性的影响。
J Clin Microbiol. 2004 Jan;42(1):269-75. doi: 10.1128/JCM.42.1.269-275.2004.
8
Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients.危重患者持续肾脏替代治疗期间头孢吡肟的药代动力学
Antimicrob Agents Chemother. 2001 Nov;45(11):3148-55. doi: 10.1128/AAC.45.11.3148-3155.2001.
9
Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosa.头孢吡肟-氨曲南:一种用于铜绿假单胞菌的独特双β-内酰胺组合。
Antimicrob Agents Chemother. 1998 Jul;42(7):1610-9. doi: 10.1128/AAC.42.7.1610.
10
Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins.产超广谱头孢菌素的阴沟肠杆菌耐药变异体的差异。
Antimicrob Agents Chemother. 1996 May;40(5):1289-93. doi: 10.1128/AAC.40.5.1289.

本文引用的文献

1
Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.阴沟肠杆菌和铜绿假单胞菌中的头孢菌素酶截留不可水解头孢菌素作为一种可能的耐药机制。
Antimicrob Agents Chemother. 1982 May;21(5):711-7. doi: 10.1128/AAC.21.5.711.
2
Effect of antibiotic use on the incidence of cephalosporin resistance in two Australian hospitals.
J Antimicrob Chemother. 1984 Sep;14 Suppl B:71-6. doi: 10.1093/jac/14.suppl_b.71.
3
Reduced sensitivity to beta-lactam antibiotics arising during ceftazidime treatment of Pseudomonas aeruginosa infections.
J Antimicrob Chemother. 1983 Oct;12(4):363-70. doi: 10.1093/jac/12.4.363.
4
Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future.新型β-内酰胺类抗生素治疗期间耐药性的出现:诱导性β-内酰胺酶的作用及对未来的影响。
Rev Infect Dis. 1983 Jul-Aug;5(4):639-48. doi: 10.1093/clinids/5.4.639.
5
The beta-lactamases of gram-negative bacteria and their possible physiological role.革兰氏阴性菌的β-内酰胺酶及其可能的生理作用。
Adv Microb Physiol. 1973;9:31-88. doi: 10.1016/s0065-2911(08)60376-8.
6
A spectrophotometric assay of beta-lactamase action on penicillins.一种关于β-内酰胺酶对青霉素作用的分光光度测定法。
Biochem J. 1974 Jun;139(3):789-90. doi: 10.1042/bj1390789.
7
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.一种使用显色头孢菌素底物检测β-内酰胺酶的新方法。
Antimicrob Agents Chemother. 1972 Apr;1(4):283-8. doi: 10.1128/AAC.1.4.283.
8
Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics.新型头孢菌素BMY 28142与其他广谱β-内酰胺类抗生素的比较。
Antimicrob Agents Chemother. 1985 Feb;27(2):207-16. doi: 10.1128/AAC.27.2.207.
9
Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams.β-内酰胺水解在产β-内酰胺酶的阴沟肠杆菌菌株对广谱β-内酰胺类抗生素耐药机制中的作用
Antimicrob Agents Chemother. 1985 Mar;27(3):393-8. doi: 10.1128/AAC.27.3.393.
10
Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections.阴沟肠杆菌感染治疗期间对头孢他啶耐药性的出现。
J Infect Dis. 1987 May;155(5):942-7. doi: 10.1093/infdis/155.5.942.